A study of BOTOX® in Patients with Idiopathic Overactive Bladder

• Research type

  Research Study

• Full title

  A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by a Treatment with BOTOX® as Applicable in Patients with Idiopathic Overactive Bladder with Urinary Incontinence

• IRAS ID

  27442

• Contact name

  Vikram Khullar

• Contact email

  vik.khullar@imperial.ac.uk

• Sponsor organisation

  Urology, EU R&D, Allergan Ltd

• Eudract number

  2009-013088-20

• Clinicaltrials.gov Identifier

  NCT00910520

• Research summary

  Research Summary not published at request of researcher

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  09/H0505/98

• Date of REC Opinion

  14 Sep 2009

• REC opinion

  Further Information Favourable Opinion